Cover Image

Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models

Saved in:

Bibliographic Details
Main Authors:	Sze-Kwan Lam (Author), Steven Eugene Mutsaers (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
by: Ranjit K Goudar
Published: (2008)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011)

Circulating biomarkers in malignant pleural mesothelioma
by: Giuseppe Viscardi, et al.
Published: (2020)

Malignant pleural mesothelioma in a child
by: Jed Brendan Scharf, et al.
Published: (2015)

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
by: Moshe Lapidot, et al.
Published: (2022)

Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
by: Sze-Kwan Lam, et al.
Published: (2022)

LOX family and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma
by: Min-Kyu Kim, et al.
Published: (2020)

Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
by: Giulio Metro, et al.
Published: (2021)

Malignant Pleural Mesothelioma. Case Report and Literature Review
by: Samuel Sánchez Sánchez, et al.
Published: (2020)

Malignant Pleural Mesothelioma. Case Report and Literature Review
by: Samuel Sánchez Sánchez, et al.
Published: (2020)

Malignant pleural epithelioid mesothelioma: A mulberry mayhem
by: Pallavi Mishra, et al.
Published: (2021)

Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas
by: Mona MLIKA, et al.
Published: (2021)

MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural Mesothelioma
by: Hannah L. Moody, et al.
Published: (2017)

Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
by: Yuzo Sato, et al.
Published: (2021)

Asbestos Exposure and Malignant Pleural Mesothelioma: A Systematic Review of Literature
by: Cátia Santos, et al.
Published: (2023)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
by: Federica Pezzuto, et al.
Published: (2021)

The Economic Impact of Clinical Research in an Italian Public Hospital: The Malignant Pleural Mesothelioma Case Study
by: Roberto Ippoliti, et al.
Published: (2018)

Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells
by: Yuzo Sato, et al.
Published: (2018)

Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods
by: Xingsheng Liu, et al.
Published: (2021)

The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion
by: Monireh Halimi, et al.
Published: (2019)

Malignant pleural mesothelioma forming a huge mediastinal mass and causing atrial fibrillation
by: Hiroko Kuwabara, et al.
Published: (2012)

Cost-effectiveness of nivolumab plus ipilimumab as first-line treatment for American patients with unresectable malignant pleural mesothelioma
by: Zhuo-miao Ye, et al.
Published: (2022)

Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods Study
by: Maguire, Roma, et al.
Published: (2020)

Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009
by: Matthew J. Soeberg, et al.
Published: (2016)

Malignant Mesothelioma
Published: (2012)

Malignant Mesothelioma
Published: (2021)

Pleural Mesothelioma: Unexpected Finding in a Young Man
by: Raza Ullah, et al.
Published: (2022)

Prognostic Significance of JMJD3 Expression in Pleural Mesotheliomas
by: Lauren Rask-Nielsen, et al.
Published: (2021)

FK228 suppress the growth of human malignant pleural mesothelioma tumor independent to epithelioid or non-epithelioid histology
by: James Mei-Lin Chan, et al.
Published: (2024)

Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing
by: Sugarbaker David J, et al.
Published: (2009)

Pleural mesothelioma risk by industry and occupation: results from the Multicentre Italian Study on the Etiology of Mesothelioma (MISEM)
by: Enrica Migliore, et al.
Published: (2022)

Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)
by: Tito R. Mendoza, et al.
Published: (2019)

Malignant paratesticular mesothelioma
by: Leonardo Gomes da Fonseca, et al.
Published: (2014)

The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011)

The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011)

Diarachidonoylphosphoethanolamine induces apoptosis of malignant pleural mesothelioma cells through a Trx/ASK1/p38 MAPK pathway
by: Ayako Tsuchiya, et al.
Published: (2015)

Pleural mesothelioma: management updates and nursing initiatives to improve patient care
by: Lehto RH
Published: (2014)

Non-Hodgkin Lymphoma and Pleural Mesothelioma in a Person Exposed to Asbestos
by: Claudio BIANCHI, et al.
Published: (2018)

Pleural multicystic mesothelial proliferation: A mimicker of benign peritoneal mesothelioma
by: Swati Agarwal, et al.
Published: (2013)